125 related articles for article (PubMed ID: 36738171)
1. HDL cholesterol and clinical outcomes in diabetes mellitus.
Ishibashi T; Kaneko H; Matsuoka S; Suzuki Y; Ueno K; Ohno R; Okada A; Fujiu K; Michihata N; Jo T; Takeda N; Morita H; Node K; Yasunaga H; Komuro I
Eur J Prev Cardiol; 2023 Jun; 30(8):646-653. PubMed ID: 36738171
[TBL] [Abstract][Full Text] [Related]
2. Different associations between HDL cholesterol and cardiovascular diseases in people with diabetes mellitus and people without diabetes mellitus: a prospective community-based study.
Wu Z; Huang Z; Lichtenstein AH; Jin C; Chen S; Wu S; Gao X
Am J Clin Nutr; 2021 Sep; 114(3):907-913. PubMed ID: 34019626
[TBL] [Abstract][Full Text] [Related]
3. Incidence of cardiovascular disease and its associated risk factors in at-risk men and women in the United Arab Emirates: a 9-year retrospective cohort study.
Al-Shamsi S; Regmi D; Govender RD
BMC Cardiovasc Disord; 2019 Jun; 19(1):148. PubMed ID: 31208354
[TBL] [Abstract][Full Text] [Related]
4. Association of Triglyceride to high-density lipoprotein cholesterol ratio and incident of diabetes mellitus: a secondary retrospective analysis based on a Chinese cohort study.
Chen Z; Hu H; Chen M; Luo X; Yao W; Liang Q; Yang F; Wang X
Lipids Health Dis; 2020 Mar; 19(1):33. PubMed ID: 32131838
[TBL] [Abstract][Full Text] [Related]
5. The association between fibrate use, change in high-density lipoprotein cholesterol, and the risk of cardiovascular disease: a retrospective chart review involving up to 8 years of follow-up.
Nichols GA; Koro CE; Chan W; Bowlin SJ; Sprecher DL
Clin Ther; 2006 Feb; 28(2):243-50. PubMed ID: 16678645
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular Disease Risk Across a Spectrum of Adverse Plasma Lipid Combinations by Gender and Glycemic Status.
Liu X; Yang Y; Kang F; Li J; Zhou M; Ma X; Yu T; Zhang T; Xue F
Am J Cardiol; 2019 Sep; 124(5):702-708. PubMed ID: 31311663
[TBL] [Abstract][Full Text] [Related]
7. Testosterone concentrations and risk of cardiovascular events in androgen-deficient men with atherosclerotic cardiovascular disease.
Boden WE; Miller MG; McBride R; Harvey C; Snabes MC; Schmidt J; McGovern ME; Fleg JL; Desvigne-Nickens P; Anderson T; Kashyap M; Probstfield JL
Am Heart J; 2020 Jun; 224():65-76. PubMed ID: 32335402
[TBL] [Abstract][Full Text] [Related]
8. Associations between serum high-density lipoprotein cholesterol levels and cause-specific mortality in a general population of 345 000 men and women aged 20-79 years.
Mørland JG; Magnus P; Vollset SE; Leon DA; Selmer R; Tverdal A
Int J Epidemiol; 2023 Aug; 52(4):1257-1267. PubMed ID: 36779319
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Association of Low-Density Lipoprotein Cholesterol With Cardiovascular Mortality in Individuals at Low 10-Year Risk of Atherosclerotic Cardiovascular Disease.
Abdullah SM; Defina LF; Leonard D; Barlow CE; Radford NB; Willis BL; Rohatgi A; McGuire DK; de Lemos JA; Grundy SM; Berry JD; Khera A
Circulation; 2018 Nov; 138(21):2315-2325. PubMed ID: 30571575
[TBL] [Abstract][Full Text] [Related]
10. Impact of low high-density lipoprotein-cholesterol level on 2-year clinical outcomes after acute myocardial infarction in patients with diabetes mellitus.
Joo HJ; Cho SA; Hong SJ; Hur SH; Bae JH; Choi DJ; Ahn YK; Park JS; Choi RK; Choi D; Kim JH; Han KR; Park HS; Choi SY; Yoon JH; Kwon HC; Rha SW; Hwang KK; Jung KT; Oh SK; Lee JH; Shin ES; Kim KS; Kim HS; Lim DS
Lipids Health Dis; 2016 Nov; 15(1):197. PubMed ID: 27863493
[TBL] [Abstract][Full Text] [Related]
11. Association of the triglyceride glucose index as a measure of insulin resistance with mortality and cardiovascular disease in populations from five continents (PURE study): a prospective cohort study.
Lopez-Jaramillo P; Gomez-Arbelaez D; Martinez-Bello D; Abat MEM; Alhabib KF; Avezum Á; Barbarash O; Chifamba J; Diaz ML; Gulec S; Ismail N; Iqbal R; Kelishadi R; Khatib R; Lanas F; Levitt NS; Li Y; Mohan V; Mony PK; Poirier P; Rosengren A; Soman B; Wang C; Wang Y; Yeates K; Yusuf R; Yusufali A; Zatonska K; Rangarajan S; Yusuf S
Lancet Healthy Longev; 2023 Jan; 4(1):e23-e33. PubMed ID: 36521498
[TBL] [Abstract][Full Text] [Related]
12. Diabetes, plasma insulin, and cardiovascular disease: subgroup analysis from the Department of Veterans Affairs high-density lipoprotein intervention trial (VA-HIT).
Rubins HB; Robins SJ; Collins D; Nelson DB; Elam MB; Schaefer EJ; Faas FH; Anderson JW
Arch Intern Med; 2002 Dec 9-23; 162(22):2597-604. PubMed ID: 12456232
[TBL] [Abstract][Full Text] [Related]
13. Discordance between the triglyceride glucose index and fasting plasma glucose or HbA1C in patients with acute coronary syndrome undergoing percutaneous coronary intervention predicts cardiovascular events: a cohort study from China.
Hu C; Zhang J; Liu J; Liu Y; Gao A; Zhu Y; Zhao Y
Cardiovasc Diabetol; 2020 Jul; 19(1):116. PubMed ID: 32703284
[TBL] [Abstract][Full Text] [Related]
14. Non-High-Density Lipoprotein Cholesterol and Risk of Cardiovascular Disease: The Japan Epidemiology Collaboration on Occupational Health Study.
Hu H; Fukunaga A; Yokoya T; Nakagawa T; Honda T; Yamamoto S; Okazaki H; Miyamoto T; Sasaki N; Ogasawara T; Gonmori N; Yamamoto K; Hori A; Tomita K; Nagahama S; Konishi M; Katayama N; Morioka H; Kabe I; Mizoue T; Dohi S
J Atheroscler Thromb; 2022 Sep; 29(9):1295-1306. PubMed ID: 34690212
[TBL] [Abstract][Full Text] [Related]
15. On-treatment non-high-density lipoprotein cholesterol, apolipoprotein B, triglycerides, and lipid ratios in relation to residual vascular risk after treatment with potent statin therapy: JUPITER (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin).
Mora S; Glynn RJ; Boekholdt SM; Nordestgaard BG; Kastelein JJ; Ridker PM
J Am Coll Cardiol; 2012 Apr; 59(17):1521-8. PubMed ID: 22516441
[TBL] [Abstract][Full Text] [Related]
16. Association of Elevated Triglycerides With Increased Cardiovascular Risk and Direct Costs in Statin-Treated Patients.
Toth PP; Philip S; Hull M; Granowitz C
Mayo Clin Proc; 2019 Sep; 94(9):1670-1680. PubMed ID: 31405751
[TBL] [Abstract][Full Text] [Related]
17. Nordic dietary patterns and cardiometabolic outcomes: a systematic review and meta-analysis of prospective cohort studies and randomised controlled trials.
Massara P; Zurbau A; Glenn AJ; Chiavaroli L; Khan TA; Viguiliouk E; Mejia SB; Comelli EM; Chen V; Schwab U; Risérus U; Uusitupa M; Aas AM; Hermansen K; Thorsdottir I; Rahelić D; Kahleová H; Salas-Salvadó J; Kendall CWC; Sievenpiper JL
Diabetologia; 2022 Dec; 65(12):2011-2031. PubMed ID: 36008559
[TBL] [Abstract][Full Text] [Related]
18. Primary Low Level of High-Density Lipoprotein Cholesterol and Risks of Coronary Heart Disease, Cardiovascular Disease, and Death: Results From the Multi-Ethnic Study of Atherosclerosis.
Ahmed HM; Miller M; Nasir K; McEvoy JW; Herrington D; Blumenthal RS; Blaha MJ
Am J Epidemiol; 2016 May; 183(10):875-83. PubMed ID: 27189327
[TBL] [Abstract][Full Text] [Related]
19. Combined association of lipids and blood pressure in relation to incident cardiovascular disease in the elderly: the cardiovascular health study.
Wong ND; Lopez VA; Roberts CS; Solomon HA; Burke GL; Kuller L; Tracy R; Yanez D; Psaty BM
Am J Hypertens; 2010 Feb; 23(2):161-7. PubMed ID: 19927131
[TBL] [Abstract][Full Text] [Related]
20. High-Density Lipoprotein Cholesterol and Cause-Specific Mortality in Individuals Without Previous Cardiovascular Conditions: The CANHEART Study.
Ko DT; Alter DA; Guo H; Koh M; Lau G; Austin PC; Booth GL; Hogg W; Jackevicius CA; Lee DS; Wijeysundera HC; Wilkins JT; Tu JV
J Am Coll Cardiol; 2016 Nov; 68(19):2073-2083. PubMed ID: 27810046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
